Moderna's COVID-19 Vaccine Shows Promise in Early-Stage Study
Posted on AllSides May 18th, 2020
From The Right
Moderna Inc. said on Monday its experimental COVID-19 vaccine showed promise in a small early-stage trial, with the vaccine producing virus-neutralizing antibodies similar to that found in recovered patients.
The news sent Moderna shares (MRNA) soaring 25%.
The company's vaccine is at the forefront of the efforts in developing a treatment for the fast-spreading virus and last week, won the U.S. health agency's "fast track" label to speed up the regulatory review. Moderna expects to start a larger late-stage trial in July.
There are currently no approved treatment or vaccine...
Some content from this outlet may be limited or behind a paywall.